Pesquisar
Milestone Pharmaceuticals Inc
MISTAdicionar à lista de desejos
1.320USD
0.0000.00%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
155.49MValor de mercado
PerdaP/L TTM
Mais detalhes de Milestone Pharmaceuticals Inc Empresa
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Informações de Milestone Pharmaceuticals Inc
Código da empresaMIST
Nome da EmpresaMilestone Pharmaceuticals Inc
Data de listagemMay 09, 2019
CEOOliveto (Joseph)
Número de funcionários33
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 09
Endereço420-1111 boul. Dr.-Frederik-Philips
CidadeMONTREAL
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísCanada
Código postalH4M 2X6
Telefone15143360444
Sitehttps://www.milestonepharma.com
Código da empresaMIST
Data de listagemMay 09, 2019
CEOOliveto (Joseph)
Executivos da empresa Milestone Pharmaceuticals Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Mr. Lorenz Muller
Mr. Lorenz Muller
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Mr. Jeffrey Nelson
Mr. Jeffrey Nelson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Milestone Pharmaceuticals Inc?
Os cinco principais acionistas de Milestone Pharmaceuticals Inc são: Dr. David Bharucha
Quantas instituições possuem ações da Milestone Pharmaceuticals Inc (MIST)?
Em 2026Q1, 133 instituições possuíam ações da Milestone Pharmaceuticals Inc, com valor de mercado aproximado de 30.89M, representando 25.86% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -18702702.00.